Patents by Inventor George V. Guittard

George V. Guittard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the management of incontinence
    Patent number: 6919092
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: July 19, 2005
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Osmotic caplet
    Patent number: 6773721
    Abstract: An osmotic caplet is disclosed comprising an osmotic caplet exit for delivering a preselected dose of drug to a patient in need of therapy.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: August 10, 2004
    Assignee: ALZA Corporation
    Inventors: Patrick S.-L. Wong, Felix Theeuwes, George V. Guittard, Atul D. Ayer
  • Method for the management of incontinence
    Publication number: 20040043943
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: August 20, 2003
    Publication date: March 4, 2004
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Publication number: 20040037881
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: August 20, 2003
    Publication date: February 26, 2004
    Inventors: George V. Guittard, Francisco Ja, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Hydrocodone therapy
    Publication number: 20030077320
    Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.
    Type: Application
    Filed: December 18, 2002
    Publication date: April 24, 2003
    Inventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S.-L. Wong
  • Hydrocodone therapy
    Patent number: 6491945
    Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: December 10, 2002
    Assignee: ALZA Corporation
    Inventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S. L. Wong
  • Method for the management of incontinence
    Patent number: 6262115
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: July 17, 2001
    Assignee: ALZA Coporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method for the management of incontinence
    Publication number: 20010005728
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: February 16, 2001
    Publication date: June 28, 2001
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Oxybutynin therapy
    Patent number: 6124355
    Abstract: A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: September 26, 2000
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Therapy for neurological diseases
    Patent number: 6036973
    Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: March 14, 2000
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Jerry D. Childers, Patrick S.-L. Wong, Fernando E. Gumucio, David J. Kidney
  • Dosage form and method for treating incontinence
    Patent number: 5912268
    Abstract: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: June 15, 1999
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando E. Gumucio
  • Method of therapy comprising an osmotic caplet
    Patent number: 5869097
    Abstract: An osmotic caplet is disclosed comprising an osmotic caplet exit for delivering a preselected dose of drug to a patient in need of therapy.
    Type: Grant
    Filed: November 2, 1992
    Date of Patent: February 9, 1999
    Assignee: Alza Corporation
    Inventors: Patrick S.-L. Wong, Felix Theeuwes, George V. Guittard, Atul D. Ayer
  • Hydrocodone therapy
    Patent number: 5866161
    Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: February 2, 1999
    Assignee: ALZA Corporation
    Inventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S.-L. Wong
  • Dosage form comprising oxybutynin
    Patent number: 5840754
    Abstract: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: November 24, 1998
    Assignee: ALZA Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando Gumucio
  • Tacrine therapy
    Patent number: 5698224
    Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: December 16, 1997
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Jerry D. Childers, Patrick S. -L. Wong, Fernando E. Gumucio, David J. Kidney
  • Dosage form comprising oxybutynin
    Patent number: 5674895
    Abstract: A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: October 7, 1997
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Francisco Jao, Susan M. Marks, David J. Kidney, Fernando Gumucio
  • Dosage form for delivering drug at a controlled rate to the intestine and to the colon
    Patent number: 5650170
    Abstract: A drug delivery device is disclosed for delivering a drug to the intestine and the colon. The device comprises external means for delaying the delivery of drug in the stomach, and hydrophobic means for preventing the passage of fluid through the delay means.
    Type: Grant
    Filed: May 6, 1991
    Date of Patent: July 22, 1997
    Assignee: Alza Corporation
    Inventors: Jeremy Corwin Wright, George V. Guittard
  • Pentoxifylline therapy and method of use
    Patent number: 5603954
    Abstract: A dosage form is disclosed for delivering pentoxifylline to a patient in need of pentoxifylline therapy. A method is discussed for delivery pentoxifylline to a patient at a dosage form controlled rate over an extended period of time.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: February 18, 1997
    Assignee: ALZA Corporation
    Inventors: Patrick S. L. Wong, George V. Guittard, Atul D. Ayer
  • Pentoxifylline therapy
    Patent number: 5532003
    Abstract: A dosage form is disclosed for delivering pentoxifylline to a patient in need of pentoxifylline therapy. A method is discussed for delivery pentoxifylline to a patient at a dosage form controlled rate over an extended period of time.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: July 2, 1996
    Assignee: ALZA Corporation
    Inventors: Patrick S.-L. Wong, George V. Guittard, Atul D. Ayer
  • Antiviral therapy
    Patent number: 5358721
    Abstract: A dosage form is disclosed for administering an antiviral drug to a patient in need of antiviral therapy.
    Type: Grant
    Filed: December 4, 1992
    Date of Patent: October 25, 1994
    Assignee: Alza Corporation
    Inventors: George V. Guittard, Patrick S. L. Wong, Anthony L. Kuczynski, David J. Kidney